4.6 Article

Model-based estimation of the economic burden of cholera in Africa

期刊

BMJ OPEN
卷 11, 期 3, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2020-044615

关键词

health economics; health policy; public health; tropical medicine

资金

  1. Swedish International Development Cooperation Agency [5410054]
  2. Korea International Cooperation Agency (KOICA) [KOICA-IVI 6/16/2017]
  3. UK Foreign, Commonwealth, and Development Office
  4. Wellcome [214662/Z/18/Z]
  5. Bill & Melinda Gates Foundation [OPP38590]
  6. Wellcome Trust [214662/Z/18/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

In 2015, an estimated 1,008,642 cases of cholera in 44 African countries resulted in an economic burden of approximately $130 million. When considering the 38,104 cholera deaths, the economic burden increased to $1 billion. These estimates are heavily dependent on factors such as cholera incidence rates, calculation of time lost due to illness and deaths, hospitalization rates, and hospitalization costs.
Objectives To estimate the economic burden of cholera in Africa. Settings Cholera affected 44 countries in Africa. Participants The analysis used data from public sources in Africa published until September 2019. Methods Based on existing data from field-based cost-of-illness studies, estimated cholera incidence rates, and reported cholera cases to WHO, this research estimates the economic burden of cholera in Africa from a societal perspective with 2015 as the base year. The estimate included out-of-pocket costs, public health system costs, productivity loss related to illness and an optional productivity loss related to premature deaths valued by the human capital approach. As various input data such as cholera incidence, hospitalisation rates and the number of workdays lost were not well defined, a series of scenario analyses and uncertainty analyses, accounting for unknowns and data variability, was conducted. Similarly, the value of time lost due to illness and deaths using the human capital approach was explored through scenario analyses. Results In 2015, an estimated 1 008 642 cases in 44 African countries resulted in an economic burden of US$130 million from cholera-related illness and its treatment. When the estimated 38 104 cholera deaths were included in the analysis, the economic burden increased to US$1 billion or international $2.4 billion for the same year. At the same time, when only the 71 126 cases and 937 deaths reported to the WHO are considered, the economic burden was only US$68 million for the year 2015. The estimates of economic burden are thus heavily dependent on the cholera incidence rate, how time lost due to illness and deaths are calculated, hospitalisation rates and hospitalisation costs. Conclusion The findings can be used as an economic justification for cholera control in Africa and for generating value-for-money evidence to underpin Ending Cholera-A Global Roadmap to 2030 with considerations to study limitations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据